TScan Therapeutics - 53 Year Dividend History | TCRX

Historical dividend payout and yield for TScan Therapeutics (TCRX) since 1971. The current TTM dividend payout for TScan Therapeutics (TCRX) as of April 12, 2024 is $0.00. The current dividend yield for TScan Therapeutics as of April 12, 2024 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.371B $0.021B
TScan Therapeutics Inc. is a biopharmaceutical company. It focused on the development of T-cell receptor engineered T cell therapies for the treatment of patients with cancer. The company's lead product pipeline consist TSC-100 and TSC-101. TScan Therapeutics Inc. is based in WALTHAM, Mass.
Stock Name Country Market Cap PE Ratio